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Conclusions: iFR and FFR had equivalent agreement with HSR classification of
coronary stenoses severity across the entire spectrum of stenosis severities. This suggests
iFR may be suitable as a vasodilator-free alternative to FFR.
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Background: The instantaneous wave-free ratio (iFR) is a vasodilator-free pressure-only
measure of coronary stenosis severity comparable to fractional flow reserve (FFR) in
diagnostic categorisation. The administration of adenosine during measurement of iFR
may lead to lower values. However, it has not been demonstrated if this would result in
an improvement in diagnostic classification. In this study we compare resting iFR and iFR
with adenosine (iFRa) to FFR and hyperaemic stenosis resistance (HSR) to determine if
adenosine administration improves the diagnostic classification of iFR.
Methods: In 51 vessels intra-coronary pressure and flow velocity was measured distal to
the stenosis at rest and during adenosine mediated hyperaemia. iFR, iFRa, FFR and HSR
were calculated using fully-automated algorithms.
Results: Mean iFR and FFR were both significantly higher than mean iFRa (0.840.2
iFR vs 0.790.2 FFR vs 0.690.2 iFRa, p0.001 for both). Despite being numerical
different, both iFR and iFRa had equivalent agreement with FFR (ROC AUC 95% iFR vs
100% iFRa, p0.15) and with HSR (ROC AUC 0.93 iFR vs 0.94 iFRa, p0.66).
Conclusions: iFR and iFRa had equivalent agreement with HSR and FFR treatment
classification of coronary stenoses. Although administration of adenosine results in lower
values of iFR, it does not lead to an improvement in treatment classification. This suggests
that providing the wave-free period can be isolated reliably, iFR can be used as an
adenosine-free pressure-only alternative to FFR.
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Background: Fractional flow reserve (FFR) is commonly reserved to assess the
functional significance of coronary lesions with intermediate stenoses. We sought to
determine the benefits and costs of routine FFR assessment in all major epicardial vessels
during elective invasive coronary angiography (IA).
Methods: 144 vessels in 48 patients with stable chest pain were assessed by IA
immediately followed by FFR in all major epicardial vessels. FFR was assumed to be 0.5
in vessels with 90% stenosis and 0.95 in smooth arteries. Interventionists recorded the
management strategy on per vessel and patient basis (revascularisation or medical
therapy) before and after knowledge of FFR results. Time taken, contrast volume and
radiation dose were documented for both components of IA and FFR.
Results: 93 vessels were successfully interrogated with FFR with no adverse effects
(mean 1.9 vessels per-patient). In the remaining 51 vessels, 26 had90% stenoses and 25
were angiographically smooth. FFR was 0.8 in 51/144 (35.4%) vessels. Based on
angiographic-findings alone, 48/144 vessels and 27/48 patients were referred for revas-
cularisation. After FFR assessment, management was altered in 16 (11%) vessels, and 11
(23%) patients. Time taken, contrast volume, radiation dose and cost for IA and FFR
components were 23mins and 30mins, 85mls and 50mls, 9.2mSv and 10.0mSv and $300
and $1060 AUD respectively.
Conclusions: Routine FFR performance in all major epicardial coronary arteries during
elective invasive angiography altered the initial angiographic-guided management in 23%
of patients and 11% of vessels. Routine FFR assessment is safe and associated with
increased procedural time, contrast volume, radiation dose and financial cost.
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Background: In CT angiography (CTA), the napkin-ring sign (NRS) is a specific marker
for coronary high-risk plaque, which may warn further evaluation by invasive imaging
like Optical Coherence Tomography (OCT). We thought to determine the visualization of
CTA-NRS lesions by OCT and its value above CTA with histology as the gold-standard.
Methods: Of human donor hearts, 9 coronary arteries were imaged by CTA, OCT, and
histology whereon coronary lesions as well presence of lipid-core plaque (LCP; fibro-
atheroma with core diameter 200m, core circumference 60°, and cap thickness
450m) were defined. Each cross-section of a lesion was evaluated for NRS in CTA
and lipid-rich plaque in OCT.
Results: In total, 292 cross-sections were assessed in CTA, OCT and histology and
grouped into 45 lesions of them 13 (29%) contained LCP. LCP lesions had higher plaque
burden (82 vs 73%, p0.01) and were longer (8 vs 5mm, p0.02) compared to non-LCP
lesions in histology. NRS in CTA had 46% sensitivity and 97% specificity to detect LCP
lesions. Containing1 cross-sections lipid-rich plaque in OCT led to moderate specificity
(66%) for LCP, but increased to 94% (p0.004) if 2 cross-sections lipid-rich plaque in
OCT were used as the positivity criteria, while sensitivity remained unchanged at 77%.
OCT was independent and incremental to CTA while area under the ROC curve for LCP
detection increased from 0.715 for CTA only to 0.898 for using both, CTA and OCT
(p0.01). Those findings remained after adjustment for confounders. Based on CTA, 7
NRS lesions were identified, of those 5 were also positive in OCT (71% agreement), all
5 lesions contained LCP in histology. Of lesions with disagreement, OCT was false
negative in one case (significant calcification associated with the necrotic core) and true
negative in the other.
Conclusions: OCT had incremental value above CTA for detecting LCP lesions as
determined by histology. However, a high sub-sequential agreement was achieved
between NRS lesions in CTA and lipid-rich lesions in OCT. Therefore NRS in CTA may
serve as a target for invasive imaging like OCT. Larger sample-size is needed for
generalization of these results.
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Background: Although frequency domain OCT (FD-OCT) has been introduced recently
in clinical practice, efficacy and feasibility of it has not been described yet in vivo in
human. Thus, the aim of this study was to compare the reliability and feasibility of
FD-OCT to intravascular ultrasound (IVUS) in coronary lesion assessment.
Methods: FD-OCT and IVUS were performed prospectively in 5 centers in 100 patients
with coronary artery disease (CAD) at the time of coronary angiography (CAG) (20 cases)
before and after stenting (60 cases) and at stent follow-up (20 cases). Quantitative analyses
were performed in minimum lumen diameter and area (MLD and MLA, respectively) in
FD-OCT, IVUS and quantitative CAG (QCA) in addition to qualitative morphological
assessment.
Results: Compared with QCA, MLD was significantly greater in OCT and IVUS (1.85
	/ 0.77 vs 1.94 	/ 0.70 vs 2.10 	/ 0.59 mm, p0.001, respectively), and it was
significantly greater in IVUS compared with OCT (p0.001), although there were
significant correlations one another (IVUS vs OCT, QCA vs OCT and QCA vs IVUS;
R20.92, 0.83 and 0.82, p0.001 respectively). MLA was also significantly greater in
IVUS compared with OCT (3.70 	/ 2.04 vs 3.36 	/ 2.28 mm2, p0.001), although
a significant correlation was observed between them (y0.85x	0.83, p0.001). Further-
more, OCT was superior to IVUS in inter-observer variability in MLA (y1.01x-0.01,
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R20.995, p0.001 vs y1.04x-0.11, R20.97, p0.001), and it was much more
sensitive in detecting tissue prolapsed (100 vs 14 %, p0.01), thrombus (7 vs 0 %,
p0.01), dissection, mal-apposition qualitatively compared with IVUS.
Conclusions: This prospective multicenter study demonstrates that much more precise
evaluation can be expected in coronary lesion by OCT compared with IVUS even in vivo
in human. FD-OCT should be more reliable and feasible in the assessment of coronary
lesion morphology more than IVUS qualitatively and quantitatively in the clinical setting.
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Background: Confirming complete neointimal coverage after implantation of a drug-
eluting stent is clinically important because incomplete stent coverage is responsible for
late thrombosis and sudden cardiac death. Optical coherence tomography (OCT) is
emerging as a promising endovascular imaging tool for the evaluation of neointimal
response after drug-eluting stent implantation. This study used OCT to compare
neointimal response between Everolimus-eluting stents (EESs) and Sirolimus-eluting
stents (SESs).
Methods: RESET trial was a prospective dual-arm randomized trial of EESs and SESs
in 3197 patients with coronary artery disease. From the RESET trial, 90 patients (EES
54, SES  55) with 1-year follow-up OCT were investigated. Image analysis was
performed at 1-mm intervals.
Results: OCT identified 9591 struts in EESs and 9425 struts in SESs. The frequency of
stent struts with neointimal coverage was significantly higher in EESs compared with
SESs (89% vs. 83%, p  0.001). The frequency of malapposed stent struts was
significantly lower in EESs compared with SESs (0.01% vs. 1%, p  0.001). Averaged
neointimal thickness (128 	/ 53 m vs. 124 	/ 73 m, p  0.751) and neointimal
volume (25.71 	/ 14.11 mm3 vs. 23.90 	/ 17.56 mm3, p  0.555) was similar in
EESs and SESs. Thrombus was observed in 2% of EESs and 11% of SESs (p  0.113).
Conclusions: In this OCT subanalysis from RESET trial, neointimal coverage was
incomplete in both EESs and SESs at 1-year after stent implantation. Uncovered struts and
malapposed struts were less observed in EESs compared with SESs.
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Background: Recent clinical trials have demonstrated that intensive lipid-lowering
therapy by statins could prevent recurrent cardiac events after acute coronary syndrome
(ACS). Optical coherence tomography (OCT) is capable of estimating fibrous cap
thickness (FCT) of coronary atherosclerotic plaques, which might be associated with
plaque instability. This study was a prospective, randomized, open-label, dual-center
study to compare the effect of intensive vs. moderate statin therapy on FCT by using OCT.
Methods: A total of 56 ACS patients with dyslipidemia [low-density lipoprotein
cholesterol (LDL-C) levels100 mg/dL] were enrolled in this study. After percutaneous
coronary intervention (PCI), the patients were randomly assigned to two groups: intensive
statin therapy (atorvastatin 20 mg/day, n27) or moderate statin therapy (atorvastatin 5
mg/day, n25). OCT was performed to measure FCT in non-culprit intermediate lesions
at baseline and 12-month follow-up. Serum profiles of LDL-C, high density lipoprotein
cholesterol (HDL-C), high sensitive C-reactive protein (hs-CRP), malondialdehyde LDL
(MDA-LDL) and metalloproteinase-9 (MMP-9) were measured before PCI and at
12-month follow-up.
Results: Serum LDL cholesterol levels were significantly decreased in patients with
intensive statin therapy (132.7 	/ 28.2 to 70.5 	/ 13.4 mg/dL, -45.4 	/ 13.0%)
compared with moderate statin therapy (129.3 	/ 31.3 to 84.9 	/ 23.8 mg/dL, -33.2
	/ 18.1%) (p 0.02). FCT was significantly increased in patients with intensive statin
therapy (119.4 	/ 46.9 to 193.0 	/ 76.0 m, 66.2 	/ 40.9%) compared with
moderate statin therapy (118.0	/ 44.3 to 142.2	/ 69.2 m, 19.8	/ 32.9%) (p
0.001). The change of FCT had a significant negative correlation with the changes in
LDL-C (r -0.49, p 0.001) and MDA-LDL (r -0.32, p 0.02), while there was no
correlation between the changes of FCT and HDL-C (r  0.06, p  0.68). Furthermore,
the change in FCT showed a negative correlation with the changes in hs-CRP (r -0.30,
p  0.03) and MMP-9 (r  -0.57, p  0.001).
Conclusions: This OCT study suggests that the intensive lipid-lowering therapy with 20
mg/day of atorvastatin might be more helpful to stabilize coronary atheros.
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Background: Favorable effects on progression of coronary atherosclerosis contribute to
the ability of statins to reduce cardiovascular events. While statins have been proposed to
also stabilize atherosclerotic plaque by lowering LDL-C level and various pleiotropic
effects, this has not been well established in vivo. High resolution imaging with optical
coherence tomography (OCT) enables visualization of microstructures related to plaque
vulnerability. Therefore, the current study investigated the impact of statin therapy on
plaque microstructures by using OCT imaging.
Methods: 102 patients with coronary artery disease underwent OCT imaging of
non-culprit lipid-rich plaque. Patients treated with (n44) and without (n58) a statin
were compared with regard to clinical characteristics and OCT-derived features of plaque
vulnerability including fibrous cap thickness and microchannels. The impact of low
(n18) and high-dose (n26) statins on OCT measures was also compared.
Results: Statin-treated patients were more likely to be male (84% vs. 60%, p0.009) and
demonstrated lower leukocyte counts (77312900 /ul vs. 91423788 /ul, p0.04) than
patients without statin therapy. OCT demonstrated that statin-treated patients were less
likely to exhibit microchannels (46% vs. 68%, p0.03), in association with a greater
fibrous cap thickness (86.049.8um vs. 72.943.0um, p0.06). Especially, patients
treated with high-dose statin therapy were less likely to demonstrate microchannels than
patients treated with lower doses (39% vs. 59%, p0.01).
Conclusions: In the current study, use of statin therapy is associated with less vulnerable
plaque features on OCT imaging. Greater OCT evidence of plaque stabilization with high-dose
statin therapy is consistent with their favorable effects on cardiovascular outcomes.
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Background: The impact of intravascular ultrasound (IVUS) guided coronary drug
eluting stent (DES) implantation on clinical outcomes remains controversial. A meta-
analysis of the currently available clinical trials investigating IVUS guided DES
implantation was undertaken.
Methods: We searched Medline, the Cochrane Library and other internet sources,
without language or date restrictions for published articles comparing clinical outcomes
between IVUS- and angiography-guided DES implantation. Clinical studies with both
adjusted and unadjusted data were included.
Results: Nine studies were identified and included in the meta-analysis with a weighted
follow-up time of 21.711.8 months. Compared with angiography-guidance, IVUS-
guided DES implantation was associated with a reduced incidence of death (hazard ratio
[HR]: 0.58, 95% confidence interval [CI]: 0.47-0.71, p0.001), major adverse cardiac
events (HR: 0.85, 95% CI: 0.76-0.95, p0.005) and stent thrombosis (HR: 0.62, 95% CI:
0.46-0.83, p0.002). The incidence of myocardial infarction (HR: 0.80, 95% CI:
0.59-1.07, p0.134), target lesion (HR: 0.97, 95% CI: 0.76-1.23, p0.782) and target
vessel (HR: 0.94, 95% CI: 0.79-1.11, p0.455) revascularization were comparable
between the angiography and IVUS-guided arms. Repeat analyses in which the IVUS
guided and the angiography guided groups had similar baseline characteristics (apart from
older patients and more renal insufficiency in the angiography guided arm) (n9049), and
analyses with studies that were propensity matched (n4,128), yielded broadly similar
results in terms of clinical outcomes.
Conclusions: IVUS-guided coronary DES implantation is associated with a significant
reduction in death, MACE and stent thrombosis compared to angiography guidance.
Appropriately powered randomized trials are necessary to confirm the findings from this
meta-analysis.
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